We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Designing Proteins Bit by Bit
Designing Proteins Bit by Bit
Blog

Cell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.

Read More

Benefits of Using 3D Cell Models in Drug Discovery
Benefits of Using 3D Cell Models in Drug Discovery
Blog

As researchers explore therapeutic strategies for more complex and heterogeneous diseases the need for more physiologically relevant models has never been greater. Researchers are increasingly looking to 3D cell cultures, spheroids, organoids and microtissues to bridge the gap between 2D cell cultures and in vivo animal models.

Read More

From Growing Cells to Growing a Business
From Growing Cells to Growing a Business
Blog

How do you start, grow and run a successful life science company? To find out we spoke to Dr Yichen Shi, CEO of Axol Bioscience.

Read More

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain
Say Hello to Regenerative Medicine and Goodbye to Back Pain
Blog

Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.

Read More

A Move Towards Precise Management of Bacterial Infections
A Move Towards Precise Management of Bacterial Infections
Blog

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

Supporting the Development of Regenerative Medicines
Supporting the Development of Regenerative Medicines
Blog

Regenerative medicine is a branch of translational research which focuses on methods to regrow, repair or replace human cells, tissues or organs. We recently spoke with Michael May, President & CEO of CCRM, an organization supporting the development of regenerative medicines and associated technologies to learn more about their latest projects and collaborations.

Read More

Accelerating the Development of Organs-on-Chips
Accelerating the Development of Organs-on-Chips
Blog

Emulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.

Read More

Novel Neuromuscular Junction Model Benefits Drug Discovery
Novel Neuromuscular Junction Model Benefits Drug Discovery
Blog

The first functional stem-cell derived neuromuscular junction model has recently been licensed, which could help the quest to develop new drugs to treat associated neurodegenerative diseases. We caught up with James Hickman, CSO, Hesperos, to learn more about the model, and some of the benefits it brings.

Read More

Harnessing Stem Cells for Blood Vessel Regeneration
Harnessing Stem Cells for Blood Vessel Regeneration
Blog

Vascugen recently announced that it had licensed stem cell technology for blood vessel regeneration at IU School of Medicine, which could lead to new treatment options for patients suffering from Peripheral Artery Disease and Critical Limb Ischemia. We caught up with Carter Cliff, CEO, Vascugen to learn more about the technology and the science behind it.

Read More

A New Generation of Flow Cytometers Advances Multiomics
A New Generation of Flow Cytometers Advances Multiomics
Blog

Flow cytometry allows the analysis of physical and biochemical features of cells. Advances in machine that can characterize and sort cells will allow researchers to look deeper than ever before into the proteome and transcriptome. We talk with Bob Balderas, VP Market Development at BD on how the cutting-edge machines like the FACSymphony S6 cell sorter incorporate new technology and advance multiomics research.

Read More